Abstract
The histidine triad nucleotide-binding protein-1 gene (HINT1) is implicated in schizophrenia and in the behavioral effects of morphine and amphetamine. Because nicotine dependence (ND) is highly comorbid with schizophrenia and other substance abuse, we examined the association of HINT1 with ND. Association analyses from two independent samples show that HINT1 gene variants are associated with ND phenotypes. Furthermore, human postmortem mRNA expression shows that smoking status and genotype influence HINT1 expression in the brain. In animal studies, western blot analyses show an increase of HINT1 protein level in the mouse nucleus accumbens (NAc) after chronic nicotine exposure. This increase was reduced after treatment with the nicotinic-receptor antagonist mecamylamine, and 24 and 72 h after cessation of nicotine treatment. These results indicate a genetic association between HINT1 variants and ND, and indicate that nicotine-induced modulation of HINT1 level may be involved in mechanisms of excess smoking.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 6 print issues and online access
$259.00 per year
only $43.17 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Accession codes
References
Klein MG, Yao Y, Slosberg ED, Lima CD, Doki Y, Weinstein IB . Characterization of PKCI and comparative studies with FHIT, related members of the HIT protein family. Exo Cell Res 1998; 244: 26–32.
Liu Q, Puche AC, Wang JB . Distribution and expression of protein kinase C interactive protein (PKCI/HINT1) in mouse central nervous system (CNS). Neurochem Res 2008; 33: 1263–1276.
Schwab SG, Eckstein GN, Hallmayer J, Lerer B, Albus M, Borrmann M et al. Evidence suggestive of a locus on chromosome 5q31 contributing to susceptibility for schizophrenia in German and Israeli families by multipoint affected sib-pair linkage analysis. Mol Psychiatry 1997; 2: 156–160.
Straub RE, MacLean CJ, O'Neill FA, Walsh D, Kendler KS . Support for a possible schizophrenia vulnerability locus in region 5q22–31 in Irish families. Mol Psychiatry 1997; 2: 148–155.
Chen X, Wang X, Hossain S, O'Neill FA, Walsh D, Pless L et al. Haplotypes spanning SPEC2, PDZ-GEF2, and ACSL6 genes are associated with schizophrenia. Hum Mol Genet 2006; 15: 3329–3342.
Vawter MP, Barrett T, Cheadle C, Sokolov BP, Wood III WH, Donovan DM et al. Application of cDNA microarrays to examine gene expression differences in schizophrenia. Brain Res Bull 2001; 55: 641–650.
Vawter MP, Crook JM, Hyde TM, Kleinman JE, Weinberger DR, Becker KG et al. Microarray analysis of gene expression in the prefrontal cortex in schizophrenia: a preliminary study. Schizophr Res 2002; 58: 11–20.
Vawter MP, Shannon WC, Ferran E, Matsumoto M, Overman K, Hyde TM et al. Gene expression of metabolic enzymes and a protease inhibitor in the prefrontal cortex are decreased in schizophrenia. Neurochem Res 2004; 29: 1245–1255.
Chen Q, Wang X, O'Neill FA, Walsh D, Kendler KS, Chen X . Is the histidine triad nucleotide-binding protein (HINT1) gene a candidate for schizophrenia? Schizophr Res 2008; 106: 200–207.
Guang W, Wang H, Su T, Weinstein IB, Wang JB . Role of mPKCI, a novel mu-opioid receptor interactive protein, in receptor desensitization, phosphorylation, and morphine-induced analgesia. Mol Pharmacol 2004; 66: 1285–1292.
Barbier E, Zapata A, Oh E, Liu Q, Zhu F, Undie A et al. Supersensitivity to amphetamine in protein kinase-C interacting protein/HINT1 knockout mice. Neuropsychopharmacology 2007; 32: 1774–1782.
de Leon J, Diaz FJ . A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors. Schizophr Res 2005; 76: 135–157.
Kendler KS, Neale MC, Sullivan P, Corey LA, Gardner CO, Prescott CA . A population-based twin study in women of smoking initiation and nicotine dependence. Psychol Med 1999; 29: 299–308.
Prescott CA, Kendler KS . Genetic and environmental contributions to alcohol abuse and dependence in a population-based sample of male twins. Am J Psychiatry 1999; 156: 34–40.
Fagerstrom KO, Schneider NG . Measuring nicotine dependence: a review of the Fagerstrom Tolerance Questionnaire. J Behav Med 1989; 12: 159–182.
Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom KO . The Fagerstrom Test for nicotine dependence: a revision of the Fagerstrom Tolerance Questionnaire. Br J Addict 1991; 86: 1119–1127.
Livak KJ . Allelic discrimination using fluorogene probes and the 5′ nuclease assay. Genet Anal 1999; 14: 143–149.
van den Oord EJ, Jiang Y, Riley BP, Kendler KS, Chen X . FP-TDI SNP scoring by manual and statistical procedures: a study of error rates and types. Biotechniques 2003; 34: 610–620, 622.
Barrett JC, Fry B, Maller J, Daly MJ . Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005; 21: 263–265.
Shi J, Levinson DF, Duan J, Sanders AR, Zheng Y, Pe'er I et al. Common variants on chromosome 6p22.1 are associated with schizophrenia. Nature 2009; 460: 753–757.
Scheet P, Stephens M . A fast and flexible statistical model for large-scale population genotype data: applications to inferring missing genotypes and haplotypic phase. Am J Hum Genet 2006; 78: 629–644.
Livak KJ, Schmittgen TD . Analysis of relative gene expression data using real-time quantitative PCR and the 2(T)(−Delta Delta C) method. Methods 2001; 25: 402–408.
Jackson KJ, Martin BR, Changeux JP, Damaj MI . Differential role of nicotinic acetylcholine receptor subunits in physical and affective nicotine withdrawal signs. J Pharmacol Exp Ther 2008; 325: 302–312.
Jackson KJ, Kota DH, Martin BR, Damaj MI . The role of various nicotinic receptor subunits and factors influencing nicotine conditioned place aversion. Neuropharmacology 2009; 56: 970–974.
Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007; 81: 559–575.
Laviolette SR, Lauzon NM, Bishop SF, Sun N, Tan H . Dopamine signaling through D1-like versus D2-like receptors in the nucleus accumbens core versus shell differentially modulates nicotine reward sensitivity. J Neurosci 2007; 28: 8025–8033.
Sellings LH, Baharnouri G, McQuade LE, Clarke PB . Rewarding and aversive effects of nicotine are segregated within the nucleus accumbens. Eur J Neurosci 2008; 28: 342–352.
Brunzell DH, Mineur YS, Neve RL, Picciotto MR . Nucleus accumbens CREB activity is necessary for nicotine conditioned place preference. Neuropsychopharmacology 2009; 34: 1993–2001.
Liechti ME, Lhuillier L, Kaupmann K, Markou A . Metabotropic glutamate 2/3 receptors in the ventral tegmental area and the nucleus accumbens shell are involved in behaviors relating to nicotine dependence. J Neurosci 2007; 27: 9077–9085.
Paterson NE, Balfour DJ, Markou A . Chronic bupropion attenuated the anhedonic component of nicotine withdrawal in rats via inhibition of dopamine reuptake in the nucleus accumbens shell. Eur J Neurosci 2007; 25: 3099–3108.
Acknowledgements
This study was supported by grants DA-019498 to XC, and DA-011287 to KSK from the National Institute on Drug Abuse and by funds from the Virginia Tobacco Settlement Foundation through the Virginia Youth Tobacco Project to Virginia Commonwealth University (subcontracted to KSK, #5100004ST). Funding support for the GAIN subjects was provided by NIMH and the genotyping of samples was provided through the GAIN organization. The data set used for the analyses described in the paper was obtained from the GAIN Database found at http://view.ncbi.nlm.nih.gov/dbgap-controlled through dbGaP accession number phs000017.v1.p1. The samples and associated phenotype data for the Linking Genome-Wide Association Study of Schizophrenia were provided by Pablo Gejman.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies the paper on the The Pharmacogenomics Journal website
PowerPoint slides
Rights and permissions
About this article
Cite this article
Jackson, K., Chen, Q., Chen, J. et al. Association of the histidine-triad nucleotide-binding protein-1 (HINT1) gene variants with nicotine dependence. Pharmacogenomics J 11, 251–257 (2011). https://doi.org/10.1038/tpj.2010.41
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/tpj.2010.41
Keywords
This article is cited by
-
The role of HINT1 in methamphetamine-induced behavioral sensitization
Psychopharmacology (2020)
-
Second messenger Ap4A polymerizes target protein HINT1 to transduce signals in FcεRI-activated mast cells
Nature Communications (2019)
-
The Role of HINT1 in Methamphetamine-Induced Conditioned Place Preference
Neurotoxicity Research (2018)
-
Post-translational modification of HINT1 mediates activation of MITF transcriptional activity in human melanoma cells
Oncogene (2017)
-
Differential expression of HINT1 in schizophrenia brain tissue
European Archives of Psychiatry and Clinical Neuroscience (2012)